Disease | pneumonia |
Phenotype | C0035204|respiratory diseases |
Sentences | 3 |
PubMedID- 26430738 | Therefore, fosfomycin has recently been recommended as an intensive care treatment for p. aeruginosa pneumonia in patients with chronic respiratory diseases [20,21]. |
PubMedID- 23751768 | Background/purpose: the bacterium chlamydia pneumoniae is associated with respiratory diseases and nonrespiratory illnesses like atherosclerosis. |
PubMedID- 25149825 | pneumonia is common in patients with respiratory diseases and/or in those who smoke, and bacteraemia is common in cancer patients [7].table 1factors associated with an increased risk of pneumococcal diseasesagehost factorsexternal factorsbehaviouralimmunocompetentimmunocompromised<2 years≥50 yearsunderlying medical conditions• ccvd• cpd• diabetes• alcoholism• cld• cerebrospinal fluid leakshivcrf, nephrotic syndromecancer (solid, haematological)organ and bone marrow transplantauto-immune diseasesimmunosuppressive therapy, corticosteroidsprimary immunodeficienciesfunctional and anatomical aspleniasocioeconomicenvironmental• preceding viral respiratory infection• residence in an institution (e.g. |
Page: 1